THE ROLE OF CORONAVIRUS INFECTION (COVID-19) IN THE DEVELOPMENT OF SYSTEMIC VASCULITIS

##plugins.themes.academic_pro.article.sidebar##

Published Mar 27, 2023
Download
PDF
Statistic
Vol. 2 No. 3 (2023): Journal of Integrated Education and Research

##plugins.themes.academic_pro.article.main##

Normuradov A.D.; Jurayeva E.R.
Department of Faculty and Hospital Therapy № 1, Occupational Pathology. Tashkent Medical Academy, Tashkent, Uzbekistan.

Abstract

The scientific article presents data on the effect of coronavirus infection on the development of systemic vasculitis. The study of options for clinical trials of systemic vasculitis in patients with coronavirus infection necessarily necessitates the use of alternative treatment tactics in time for this disease, and as a result, complications of the disease are prevented, and in patients with a complicated or chronic form of the disease, the transition of the disease in a mild form and a significant decrease in This assesses how significant medicamentous therapy is. The Prevention of risk factors, analysis of the clinical course of systemic vasculitis and changes in laboratory-instrumental examinations serve to identify the disease in time, reduce the risk of its complications for a while, and bring the lethality rate to a minimum. The results of scientific research are recommended for use in the activities of doctors. The results obtained are recommended for use in the process of teaching students of medical institutes.

##plugins.themes.academic_pro.article.details##

How to Cite
Normuradov A.D.; Jurayeva E.R. (2023). THE ROLE OF CORONAVIRUS INFECTION (COVID-19) IN THE DEVELOPMENT OF SYSTEMIC VASCULITIS. Journal of Integrated Education and Research, 2(3), 23–27. Retrieved from https://ojs.rmasav.com/index.php/ojs/article/view/880

References

  1. Beketova T.V., Nasonov Ye.V. Vasculopathy U patsientov s COVID-19 tyajelogo techeniya. Klinicheskaya meditsina. 2020;98(5):325-333. https://doi.org/10.30629/0023-2149-2020-98-5-325-333
  2. Beketova T.V., Nasonov E.V. Vasculopathy in patients with severe COVID-19 infection. Clinical Medicine (Russian Journal). 2020;98(5):325-333. (In Russ.) https://doi.org/10.30629/0023-2149-2020-98-5-325-333
  3. Novikov, P. I. Klinicheskaya otsenka variantov techeniya I prognosis granulematoza s poliangiitom (Vegenera) : dis. ... kand. med. nauk / P. I. Novikov. — M., 2014. — 113 P.
  4. Semenkova, Ye. N. Sistemnie vasculiti / Ye. N. Semenkova. — M. : Medicine, 1988. — 238 P.
  5. Semenkova, Ye. N. Sistemnie necratiziroyutshie vasculiti / Ye. N. Semenkova. — M. : Russky vrach, 2001. — 95 P.
  6. Strijakov, L. A. Porajenie serdtsa pri sistemnix vaskulitax : klinicheskie variant, znachenie faktorov riska atherosclerosis v razvitii serdechno-sosudistix oslojneniy I vozmojnosti neinvazivnix metodov diagnostic: dis. ... d-ra med. nauk / L. A. Strijakov. — M., 2013. — 192 P.
  7. Bhamra, K. Damage assessment in ANCA-associated vasculitis /
  8. K. Bhamra, R. Bite / / Current rheumatology reports. — 2012. - Vol. 14. — № 6. — P. 494-500.
  9. Gattinoni L, Chiumello D, Caironi P, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med 2020;46(6): 1099-102.
  10. Grasselli G, Tonetti T, Protti A, et al. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med 2020:S2213-2600(20)30370-2.
  11. Marini JJ, Gattinoni L. Management of COVID-19 respiratory distress. JAMA 2020;323(22):2329-30.
  12. Li X, Ma X. Acute respiratory failure in COVID-19: is it "typical" ARDS? Crit Care 2020;24(1):198.
  13. Ciceri F, Beretta L, Scandroglio AM, et al. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acuterespiratory distress syndrome working hypothesis. Crit Care Resusc 2020;22:95-7.